78% mortality reduction in ICU-admitted COVID-19 patients in Suriname after treatment with convalescent plasma (CP) obtained by the HemoClear blood filter.
HemoClear B.V. received CE Mark approval for its first-in-class, technology, the HemoClearTM autologous blood filter
As a proud sponsor, HemoClear is attending the 28th Nigerian Society of Anaesthetists Annual Scientific Conference. Dr Rosita Bihariesingh has been at the
HemoClear attends the Bloodless Medicine & Surgery Society 2020 Annual Scientific Conference. Our Chief Medical Officer, Dr Arno Nierich, will present
COVID-19 plasma donatie geeft vroeg in het genezingsproces een hogere opbrengst van antistoffen dan later in dat proces. https://www.rtvoost.nl/nieuws/1271
Zwolle, 14 september 2020. Het Academisch Medisch Centrum (AZP) in Paramaribo, Suriname, heeft met succes onderzoek gedaan naar een efficiënte methode om
The renowned European Institute for Innovation and Technology (EIT) has selected HemoClear to participate in the Bridgehead Europe programme. Best-in-class
In times of crisis, it is good to have a partner like Oost NL. Where possible they show financial leniency and they bring proactive other support options t
An estimated 4 million women need a blood transfusion after giving birth annually. Now new research has found that their pregnancies put these women are at
8 April 2020, Zwolle – In the fight against COVID-19, HemoClear’s current top priority is to help save lives, with COVID-19 convalescent plasma the